In vitro Antibacterial Activities of New Fluoroquinolones against Clinical Isolates of Haemophilus influenzae with Ciprofloxacin-Resistance-Associated Alterations in GyrA and ParC
- 1 December 2004
- journal article
- Published by S. Karger AG in Chemotherapy
- Vol. 50 (6) , 265-275
- https://doi.org/10.1159/000082624
Abstract
The in vitro antimicrobial activities of new fluoroquinolones were tested against quinolone-resistant Haemophilus influenzae of clinical isolates. The nucleotide sequences of the gyrA and parC genes from three ciprofloxacin-resistant strains of Haemophilus influenzae (MIC, 1.56-6.25 microg/ml) were determined. The gyrase was purified from the clinical isolates, and the inhibitory activities of quinolones against the enzyme were tested. These strains possessed at least one amino acid substitution in each of the GyrA (asparagine at residue 88 (Asp-88) to Tyr, Ser-84 to Leu or Ser-84 to Leu and Asp-88 to Asn) and ParC (Glu-88 to Lys). The antibacterial activity of olamufloxacin against the resistant strains was most potent compared with other quinolones, and the inhibitory activities correlated with quinolone resistance of these strains. These results warrant the clinical effects of new types of fluoroquinolones, such as olamufloxacin, against respiratory tract and otolaryngology infections caused by ciprofloxacin-resistant H. influenzae.Keywords
This publication has 16 references indexed in Scilit:
- Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trialsThe Lancet Infectious Diseases, 2003
- Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance ProgramDiagnostic Microbiology and Infectious Disease, 2003
- Fluoroquinolone Safety in Pediatric Patients: A Prospective, Multicenter, Comparative Cohort Study in FrancePublished by American Academy of Pediatrics (AAP) ,2003
- Antimicrobial Susceptibilities of 1,730 Haemophilus influenzae Respiratory Tract Isolates in Spain in 1998-1999Antimicrobial Agents and Chemotherapy, 2001
- Present Status of Antimicrobial Susceptibility of Haemophilus influenzae Isolates in Kuwait as Determined by E-TestMedical Principles and Practice, 2001
- Worldwide Prevalence of Antimicrobial Resistance inStreptococcus pneumoniae, Haemophilus influenzae,andMoraxella catarrhalisin the SENTRY Antimicrobial Surveillance Program, 1997–1999Clinical Infectious Diseases, 2001
- Increasing Prevalence of Ampicillin- Resistant, Non-Beta-Lactamase-Producing Strains of Haemophilus influenzae in Children in JapanChemotherapy, 1999
- Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from The NetherlandsJournal of Antimicrobial Chemotherapy, 1997
- Magnetic Resonance Imaging in Children Receiving Quinolones: No Evidence of Quinolone-lnduced ArthropathyChemotherapy, 1994
- Safety of ciprofloxacin in children: Worldwide clinical experience based on compassionate use. Emphasis on joint evaluationInfection, 1991